vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.

PROCORE TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($349.1M vs $270.8M, roughly 1.3× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -10.8%, a 11.5% gap on every dollar of revenue. On growth, PROCORE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (15.6% vs -16.5%). PROCORE TECHNOLOGIES, INC. produced more free cash flow last quarter ($109.2M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.

HCM vs PCOR — Head-to-Head

Bigger by revenue
PCOR
PCOR
1.3× larger
PCOR
$349.1M
$270.8M
HCM
Growing faster (revenue YoY)
PCOR
PCOR
+32.1% gap
PCOR
15.6%
-16.5%
HCM
Higher net margin
HCM
HCM
11.5% more per $
HCM
0.7%
-10.8%
PCOR
More free cash flow
PCOR
PCOR
$105.9M more FCF
PCOR
$109.2M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
PCOR
PCOR
Revenue
$270.8M
$349.1M
Net Profit
$2.0M
$-37.6M
Gross Margin
37.7%
80.1%
Operating Margin
-13.2%
-12.3%
Net Margin
0.7%
-10.8%
Revenue YoY
-16.5%
15.6%
Net Profit YoY
-83.6%
39.6%
EPS (diluted)
$0.00
$-0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PCOR
PCOR
Q4 25
$270.8M
$349.1M
Q3 25
$338.9M
Q2 25
$277.7M
$323.9M
Q1 25
$324.5M
$310.6M
Q4 24
$302.0M
Q3 24
$295.9M
Q2 24
$305.7M
$284.3M
Q1 24
$269.4M
Net Profit
HCM
HCM
PCOR
PCOR
Q4 25
$2.0M
$-37.6M
Q3 25
$-9.1M
Q2 25
$455.0M
$-21.1M
Q1 25
$11.9M
$-33.0M
Q4 24
$-62.3M
Q3 24
$-26.4M
Q2 24
$25.8M
$-6.3M
Q1 24
$-11.0M
Gross Margin
HCM
HCM
PCOR
PCOR
Q4 25
37.7%
80.1%
Q3 25
79.7%
Q2 25
0.1%
79.1%
Q1 25
48.0%
79.1%
Q4 24
81.2%
Q3 24
81.4%
Q2 24
41.1%
83.1%
Q1 24
83.0%
Operating Margin
HCM
HCM
PCOR
PCOR
Q4 25
-13.2%
-12.3%
Q3 25
-4.4%
Q2 25
-1.3%
-9.3%
Q1 25
-5.0%
-11.7%
Q4 24
-21.9%
Q3 24
-12.3%
Q2 24
-9.0%
-5.2%
Q1 24
-7.0%
Net Margin
HCM
HCM
PCOR
PCOR
Q4 25
0.7%
-10.8%
Q3 25
-2.7%
Q2 25
163.8%
-6.5%
Q1 25
3.7%
-10.6%
Q4 24
-20.6%
Q3 24
-8.9%
Q2 24
8.4%
-2.2%
Q1 24
-4.1%
EPS (diluted)
HCM
HCM
PCOR
PCOR
Q4 25
$0.00
$-0.25
Q3 25
$-0.06
Q2 25
$0.52
$-0.14
Q1 25
$0.01
$-0.22
Q4 24
$-0.42
Q3 24
$-0.18
Q2 24
$0.03
$-0.04
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PCOR
PCOR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$768.5M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$1.3B
Total Assets
$1.8B
$2.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PCOR
PCOR
Q4 25
$1.4B
$768.5M
Q3 25
$684.0M
Q2 25
$1.4B
$620.9M
Q1 25
$836.1M
$566.7M
Q4 24
$775.4M
Q3 24
$756.9M
Q2 24
$802.5M
$735.4M
Q1 24
$744.6M
Total Debt
HCM
HCM
PCOR
PCOR
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
PCOR
PCOR
Q4 25
$1.2B
$1.3B
Q3 25
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$759.9M
$1.2B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$740.1M
$1.3B
Q1 24
$1.2B
Total Assets
HCM
HCM
PCOR
PCOR
Q4 25
$1.8B
$2.2B
Q3 25
$2.1B
Q2 25
$1.8B
$2.0B
Q1 25
$1.3B
$1.9B
Q4 24
$2.1B
Q3 24
$2.0B
Q2 24
$1.3B
$2.0B
Q1 24
$1.9B
Debt / Equity
HCM
HCM
PCOR
PCOR
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PCOR
PCOR
Operating Cash FlowLast quarter
$8.2M
$114.9M
Free Cash FlowOCF − Capex
$3.4M
$109.2M
FCF MarginFCF / Revenue
1.2%
31.3%
Capex IntensityCapex / Revenue
1.8%
1.6%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$282.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PCOR
PCOR
Q4 25
$8.2M
$114.9M
Q3 25
$88.5M
Q2 25
$-72.9M
$30.8M
Q1 25
$40.3M
$66.0M
Q4 24
$29.1M
Q3 24
$39.3M
Q2 24
$-39.8M
$58.7M
Q1 24
$69.1M
Free Cash Flow
HCM
HCM
PCOR
PCOR
Q4 25
$3.4M
$109.2M
Q3 25
$83.1M
Q2 25
$-82.2M
$27.9M
Q1 25
$32.5M
$62.0M
Q4 24
$17.4M
Q3 24
$35.7M
Q2 24
$-49.9M
$56.8M
Q1 24
$67.1M
FCF Margin
HCM
HCM
PCOR
PCOR
Q4 25
1.2%
31.3%
Q3 25
24.5%
Q2 25
-29.6%
8.6%
Q1 25
10.0%
20.0%
Q4 24
5.8%
Q3 24
12.1%
Q2 24
-16.3%
20.0%
Q1 24
24.9%
Capex Intensity
HCM
HCM
PCOR
PCOR
Q4 25
1.8%
1.6%
Q3 25
1.6%
Q2 25
3.3%
0.9%
Q1 25
2.4%
1.3%
Q4 24
3.9%
Q3 24
1.2%
Q2 24
3.3%
0.7%
Q1 24
0.8%
Cash Conversion
HCM
HCM
PCOR
PCOR
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

PCOR
PCOR

US$298.3M85%
Non Us$50.9M15%

Related Comparisons